Lancet Neurology, The, ISSN 1474-4422, 2017, Volume 16, Issue 5, pp. 377 - 389
Summary Background No large trials have been done to investigate the efficacy of an intervention combining a specific compound and several lifestyle...
Neurology | DEMENTIA | PLASMA | ALZHEIMERS-DISEASE | PERFORMANCE | PREVENTION | RISK | GAIT SPEED | BRAIN | CLINICAL NEUROLOGY | DECLINE | Double-Blind Method | Humans | Male | Treatment Outcome | Cognition - drug effects | Exercise Therapy | Neuropsychological Tests | Memory Disorders - prevention & control | Aged, 80 and over | Fatty Acids, Omega-3 - therapeutic use | Cognitive Therapy | Female | Aged | Dietary Supplements | Clinical trials | Fatty acids | Intervention | Physical training | Physical activity | Gait | Polyunsaturated fatty acids | Memory | Cognitive ability | Docosahexaenoic acid | Exercise | Motivation | Older people | Supplementation | Fish oils | Dietary supplements | Medical screening | Disease prevention | Studies | Physical fitness | Cognition & reasoning | Lifestyles | Alzheimers disease | Eicosapentaenoic acid | Geriatrics | Dementia | Life Sciences | Food and Nutrition | Biochemistry, Molecular Biology
Neurology | DEMENTIA | PLASMA | ALZHEIMERS-DISEASE | PERFORMANCE | PREVENTION | RISK | GAIT SPEED | BRAIN | CLINICAL NEUROLOGY | DECLINE | Double-Blind Method | Humans | Male | Treatment Outcome | Cognition - drug effects | Exercise Therapy | Neuropsychological Tests | Memory Disorders - prevention & control | Aged, 80 and over | Fatty Acids, Omega-3 - therapeutic use | Cognitive Therapy | Female | Aged | Dietary Supplements | Clinical trials | Fatty acids | Intervention | Physical training | Physical activity | Gait | Polyunsaturated fatty acids | Memory | Cognitive ability | Docosahexaenoic acid | Exercise | Motivation | Older people | Supplementation | Fish oils | Dietary supplements | Medical screening | Disease prevention | Studies | Physical fitness | Cognition & reasoning | Lifestyles | Alzheimers disease | Eicosapentaenoic acid | Geriatrics | Dementia | Life Sciences | Food and Nutrition | Biochemistry, Molecular Biology
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2006, Volume 28, Issue 4, pp. 560 - 568
Anesthetics with a short context-sensitive half-time (ie, the time required for the effect-site concentration of an IV drug to decrease by 50% at steady...
sufentanil | extubation time | remifentanil | intracranial surgery | cost analysis | CONSCIOUSNESS | ABDOMINAL-SURGERY | ALFENTANIL | RECOVERY | PHARMACOKINETICS | CONTROLLED INFUSION | SUPRATENTORIAL CRANIOTOMY | NEUROSURGICAL PROCEDURES | PHARMACOLOGY & PHARMACY | FENTANYL | RATIONAL OPIOID SELECTION | Anesthetics, Intravenous - adverse effects | Costs and Cost Analysis | Prospective Studies | Double-Blind Method | Humans | Meningioma - surgery | Middle Aged | Male | Anesthesia, General - adverse effects | Supratentorial Neoplasms - surgery | Neurosurgical Procedures | Piperidines - adverse effects | Endpoint Determination | Adult | Brain - surgery | Craniotomy | Female | Aged | Hemodynamics | Glioma - surgery | Intubation, Intratracheal | Sufentanil - adverse effects | Monitoring, Intraoperative | Propofol - adverse effects | Clinical trials | Adults | Comparative analysis | Surgery
sufentanil | extubation time | remifentanil | intracranial surgery | cost analysis | CONSCIOUSNESS | ABDOMINAL-SURGERY | ALFENTANIL | RECOVERY | PHARMACOKINETICS | CONTROLLED INFUSION | SUPRATENTORIAL CRANIOTOMY | NEUROSURGICAL PROCEDURES | PHARMACOLOGY & PHARMACY | FENTANYL | RATIONAL OPIOID SELECTION | Anesthetics, Intravenous - adverse effects | Costs and Cost Analysis | Prospective Studies | Double-Blind Method | Humans | Meningioma - surgery | Middle Aged | Male | Anesthesia, General - adverse effects | Supratentorial Neoplasms - surgery | Neurosurgical Procedures | Piperidines - adverse effects | Endpoint Determination | Adult | Brain - surgery | Craniotomy | Female | Aged | Hemodynamics | Glioma - surgery | Intubation, Intratracheal | Sufentanil - adverse effects | Monitoring, Intraoperative | Propofol - adverse effects | Clinical trials | Adults | Comparative analysis | Surgery
Journal Article
GeroScience, ISSN 2509-2715, 8/2017, Volume 39, Issue 4, pp. 429 - 437
Studies have shown that omega-3 polyunsaturated fatty acids (PUFAs) are associated with brain, cardiovascular, and immune function, as well as physical...
Life Sciences | Gait speed | Physical performance | Geriatrics/Gerontology | Omega-3 polyunsaturated fatty acids | SPPB | Molecular Medicine | MAPT | Cell Biology | OLDER-ADULTS | LOWER-EXTREMITY FUNCTION | DIETARY-INTAKE | OMEGA-3 INDEX | GERIATRICS & GERONTOLOGY | RISK-FACTOR | DISABILITY | POLYUNSATURATED FATTY-ACIDS | FISH-OIL | CORONARY-HEART-DISEASE | Membranes | Immune response | Physical activity | Gait | Polyunsaturated fatty acids | Memory | Cognitive ability | Cell membranes | Docosahexaenoic acid | Fatty acids | Studies | Body mass index | Older people | Eicosapentaenoic acid
Life Sciences | Gait speed | Physical performance | Geriatrics/Gerontology | Omega-3 polyunsaturated fatty acids | SPPB | Molecular Medicine | MAPT | Cell Biology | OLDER-ADULTS | LOWER-EXTREMITY FUNCTION | DIETARY-INTAKE | OMEGA-3 INDEX | GERIATRICS & GERONTOLOGY | RISK-FACTOR | DISABILITY | POLYUNSATURATED FATTY-ACIDS | FISH-OIL | CORONARY-HEART-DISEASE | Membranes | Immune response | Physical activity | Gait | Polyunsaturated fatty acids | Memory | Cognitive ability | Cell membranes | Docosahexaenoic acid | Fatty acids | Studies | Body mass index | Older people | Eicosapentaenoic acid
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 1999, Volume 21, Issue 8, pp. 1313 - 1320
This retrospective, unmasked chart review was undertaken to determine which HIV-infected patients receiving protease inhibitors (PIs) for the first time were...
protease inhibitors | indinavir | highly active antiretroviral therapy | viral load | HIV | Highly active antiretroviral therapy | Protease inhibitors | Viral load | Indinavir | PROTEASE INHIBITOR THERAPY | VIROLOGICAL TREATMENT FAILURE | PREDICTORS | IMMUNODEFICIENCY-VIRUS INFECTION | PHARMACOLOGY & PHARMACY | COHORT | HIV-1 INFECTION | Antiviral Agents - therapeutic use | Humans | Male | Clinical Trials as Topic | Data Collection | Saquinavir - therapeutic use | CD4-Positive T-Lymphocytes - physiology | Retroviridae - drug effects | Viral Load | Polymerase Chain Reaction | Lymphocyte Count | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Retrospective Studies | Protease Inhibitors - therapeutic use | Indinavir - therapeutic use | Antiviral agents | Proteases | Analysis | HIV patients | T cells | Anti-HIV agents
protease inhibitors | indinavir | highly active antiretroviral therapy | viral load | HIV | Highly active antiretroviral therapy | Protease inhibitors | Viral load | Indinavir | PROTEASE INHIBITOR THERAPY | VIROLOGICAL TREATMENT FAILURE | PREDICTORS | IMMUNODEFICIENCY-VIRUS INFECTION | PHARMACOLOGY & PHARMACY | COHORT | HIV-1 INFECTION | Antiviral Agents - therapeutic use | Humans | Male | Clinical Trials as Topic | Data Collection | Saquinavir - therapeutic use | CD4-Positive T-Lymphocytes - physiology | Retroviridae - drug effects | Viral Load | Polymerase Chain Reaction | Lymphocyte Count | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Retrospective Studies | Protease Inhibitors - therapeutic use | Indinavir - therapeutic use | Antiviral agents | Proteases | Analysis | HIV patients | T cells | Anti-HIV agents
Journal Article
The American Journal of Medicine, ISSN 0002-9343, 1992, Volume 93, Issue 4, pp. 476 - 476
Journal Article
Oncotarget, ISSN 1949-2553, 2015, Volume 6, Issue 35, pp. 37471 - 37485
eIF6 is an antiassociation factor that regulates the availability of active 80S. Its activation is driven by the RACK1/PKCβ axis, in a mTORc1 independent...
EIF6 phosphorylation | Malignant pleural mesothelioma | PKCbeta | Enzastaurin | Anti-association activity | Up-Regulation | Phosphorylation | Pleural Neoplasms - genetics | Cell Proliferation | Mesothelioma - pathology | Humans | Gene Expression Regulation, Neoplastic | Pleural Neoplasms - metabolism | Transfection | RNA Interference | Time Factors | Adenosine Triphosphate - metabolism | Biomarkers, Tumor - metabolism | Indoles - pharmacology | Protein Stability | Pleural Neoplasms - pathology | Eukaryotic Initiation Factors - genetics | Eukaryotic Initiation Factors - metabolism | Mesothelioma - therapy | Signal Transduction | Mesothelioma - genetics | Tumor Burden | Mice, SCID | Pleural Neoplasms - therapy | Xenograft Model Antitumor Assays | Animals | Mesothelioma - metabolism | Cell Line, Tumor | Glycolysis | Mice, Inbred NOD | Protein Kinase C beta - metabolism | Biomarkers, Tumor - genetics | Protein Kinase Inhibitors - pharmacology | RNAi Therapeutics | Protein Kinase C beta - antagonists & inhibitors
EIF6 phosphorylation | Malignant pleural mesothelioma | PKCbeta | Enzastaurin | Anti-association activity | Up-Regulation | Phosphorylation | Pleural Neoplasms - genetics | Cell Proliferation | Mesothelioma - pathology | Humans | Gene Expression Regulation, Neoplastic | Pleural Neoplasms - metabolism | Transfection | RNA Interference | Time Factors | Adenosine Triphosphate - metabolism | Biomarkers, Tumor - metabolism | Indoles - pharmacology | Protein Stability | Pleural Neoplasms - pathology | Eukaryotic Initiation Factors - genetics | Eukaryotic Initiation Factors - metabolism | Mesothelioma - therapy | Signal Transduction | Mesothelioma - genetics | Tumor Burden | Mice, SCID | Pleural Neoplasms - therapy | Xenograft Model Antitumor Assays | Animals | Mesothelioma - metabolism | Cell Line, Tumor | Glycolysis | Mice, Inbred NOD | Protein Kinase C beta - metabolism | Biomarkers, Tumor - genetics | Protein Kinase Inhibitors - pharmacology | RNAi Therapeutics | Protein Kinase C beta - antagonists & inhibitors
Journal Article
The journal of nutrition, health & aging, ISSN 1279-7707, 4/2019, Volume 23, Issue 4, pp. 386 - 392
This study aimed to examine the associations of three operational definitions of vitality with variation in instrumental activities of daily living (IADL) and...
frailty | Neurosciences | Medicine & Public Health | Nutrition | cognition | Geriatrics/Gerontology | elderly | activities of daily living | Aging | Quality of Life Research | Primary Care Medicine | Vitality | PHYSICAL PERFORMANCE | GRIP STRENGTH | COGNITIVE FUNCTION | DECLINE | GERIATRICS & GERONTOLOGY | NUTRITION & DIETETICS | HANDGRIP STRENGTH | QUALITY-OF-LIFE | HEALTH | INCIDENT DISABILITY | Reservoirs | Aged | Activities of daily living | Alzheimer's disease | Analysis | Depression, Mental
frailty | Neurosciences | Medicine & Public Health | Nutrition | cognition | Geriatrics/Gerontology | elderly | activities of daily living | Aging | Quality of Life Research | Primary Care Medicine | Vitality | PHYSICAL PERFORMANCE | GRIP STRENGTH | COGNITIVE FUNCTION | DECLINE | GERIATRICS & GERONTOLOGY | NUTRITION & DIETETICS | HANDGRIP STRENGTH | QUALITY-OF-LIFE | HEALTH | INCIDENT DISABILITY | Reservoirs | Aged | Activities of daily living | Alzheimer's disease | Analysis | Depression, Mental
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.